Skip to main content
ROHTO PHARMACEUTICAL CO.,LTD. logo

ROHTO PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4527 ISIN · JP3982400008 LEI · 353800Q1CW5OS81OUM12 T Manufacturing
Open in API
Filings indexed 74 across all filing types
Latest filing 2023-11-13 Interim / Quarterly Rep…
Country JP Japan
Listing T 4527

About ROHTO PHARMACEUTICAL CO.,LTD.

https://www.rohto.co.jp/global/

Rohto Pharmaceutical Co., Ltd. is a multinational company that manufactures and markets a wide range of health and beauty care products. The company's core business areas are over-the-counter (OTC) pharmaceuticals and skincare. It is a recognized leader in the eye care market, particularly known for its extensive line of eye drops. The product portfolio also includes skincare, oral medications, and functional foods. Rohto Pharmaceutical focuses on research and development to create innovative products and services that support the physical and mental well-being of consumers worldwide, aiming to contribute to the future potential of society through health.

Recent filings

Filing Released Lang Actions
四半期報告書－第88期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It covers the second quarter of the 88th fiscal period (July 1, 2023, to September 30, 2023) for Rohto Pharmaceutical Co., Ltd. It contains detailed financial statements, management analysis (MDA), and corporate information, which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-13 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification confirming the accuracy of the quarterly report (四半期報告書) for the first quarter of the 88th fiscal period. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type, should be classified as Regulatory Filings (RNS) rather than the report itself. Q1 88
2023-08-10 Japanese
四半期報告書－第88期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Rohto Pharmaceutical Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet, for the first quarter of the 88th fiscal period (April 1, 2023, to June 30, 2023). It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-10 Japanese
内部統制報告書－第87期(2022/04/01－2023/03/31)
Audit Report / Information Classification · 95% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). It details the framework, scope, and results of the company's internal controls over financial reporting as of the fiscal year-end. This type of document is a standalone audit-related report concerning internal control systems, which falls under the 'Audit Report / Information' category. FY 2023
2023-06-29 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It is a mandatory regulatory filing that accompanies the Annual Securities Report (Yuuka Shouken Houkokusho) to confirm the accuracy of the financial statements. Since it is a specific regulatory filing required by law and does not fit into the other categories like 10-K or IR, it is classified as a Regulatory Filing (RNS). FY 2023
2023-06-29 Japanese
有価証券報告書－第87期(2022/04/01－2023/03/31)
Annual Report Classification · 100% confidence The document header explicitly identifies itself as an '有価証券報告書' (Yukashoken Hokokusho), which is the Japanese equivalent of an Annual Report (10-K). It includes the fiscal year (第87期, 2022-04-01 to 2023-03-31), the company name (Rohto Pharmaceutical Co., Ltd.), and regulatory filing details under the Financial Instruments and Exchange Act. The content contains extensive XBRL-like tagging and financial data structures typical of a comprehensive annual filing. FY 2023
2023-06-29 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.